HGH Products With IGF-1 Clinical Studies

The products whose human growth hormone formulas have undergone double-blind placebo-controlled IGF-1 clinical trials to measure effectiveness are listed below. IGF-1 levels are used to measure the amount of human growth hormone in the body. If a brand is not listed below it's because that brand has not had any legitimate IGF-1 clinical studies to prove whether it can actually increase human growth hormone in the body.

ProBLEN (our Brand)

Physician Supervised Clinical Study Results (our clinical studies)

Overall Average IGF-1 Change: +160.6%
Clinical Studies by Dr. Juan Hernandez Flores, Lic., and Irais Castellanos Mungula, at the Centro Geriatrico Naturista, Mexico D.F. (click here for our clinical study specifics)

Nu-Spring*

Clinical Studies

Average Change: +105.8%
(FOD #619-824-3423 #7 - #14) (Total study included 18 people - average is of that total group)

*If you compare the results of Nu-Spring and PRO-Symbio Plus you will notice that it appears they reported some of the same results. For instance, Nu-Spring's patient 4 is identical to PRO-Symbio's patient 2. Perhaps both brands use the same formula.

PRO-Symbio PLUS*

Clinical Studies

Overall Average Change: +105.8%
Overall Average Days: 68.6 days

Regenesis 1

Identical to LifeSpan I
Clinical Results

Average Change: +82.8%
(Total study included 23 people - average is of that total group)

Pro-hGH

Physician Supervised Clinical Studies

Average Change: +57.06%

Rejuvamin

Clinical Study- Complete Results
REJUVAMIN QID 2 GRAMS - SIX WEEK DURATION

Average Change: +56.8%
(Total study included 12 people - average is of that total group) Clinical Study carried out by Dr. Timothy Bassett and Dr. Steven Smith at the LiFExtension Institute

Eden GH-1

Clinical Test Studies

Average Change: +44.09%
(Total study included 35 people - average is of that total group)

Biogevity

Research Studies- In outcome based research studies performed on 20 subjects supplementing with BioGevity for up to 26 weeks, 75% of subjects (15 people) experienced a 41% average increase in IGF-1 levels (insulin-like growth factor-1, a stable indicator of Somatotropin levels).

Total Increases for 75% of Subjects: +41%
(results of 15 subjects given, results of other 5 subjects not given)

Other Brands of HGH Products

The Specifics of our ProBLEN IGF-1 Clinical Studies.

Information About Proper IGF-1 Clinical Testing and the False or Misleading Reporting Some Use.

Our Pharmaceutical Lab's Survey of Clients Taking ProBLEN Human Growth Hormone.